Immunology at M D Anderson Aims to Predict Cancer Prognosis
Houston researchers describe an immunosurveillance lab at M D Anderson to test patients for immunity to fungi bacteria yeasts and viruses and to assess responses to antitumor immunotherapy. Dr Evan M Hersh notes prognosis relies on tumor size plus immune status and other clinical tests. Immunotherapy is viewed as a way to raise remission rates and extend survival by boosting general and tumor specific immunity.